Search
DeSci-focused DAO community funds cancer research
17.10.2023
VitaDAO community agreed to fund an early-stage cancer research through the launch of a biotech company named Matrix Biosciences
Today in Crypto: Avant Arte & Yuga Labs Set to Bring 10,000 CryptoPunks Into the Physical Realm, Pfizer-backed VitaDAO Launches Biotech Firm for Longevity Experiments on Animals
9.10.2023
Get your daily, bite-sized digest of cryptoasset and blockchain-related news – investigating the stories flying under the radar of today’s crypto news.__________...
Read More: Today in Crypto: Avant Arte & Yuga Labs Set to Bring 10,000 CryptoPunks Into the Physical Realm, Pfizer-backed VitaDAO...
Protocol Village: VitaDAO, a ‘DeSci DAO,’ Launches Matrix Biosciences
9.10.2023
The latest in blockchain tech upgrades, funding announcements and deals. For the week of Oct. 9-15, with live updates throughout
Pfizer-Backed VitaDAO Votes on Creating For-Profit Company to Fund Longevity Research
5.4.2023
The DAOs native token, VITA, rose 3% on news the community was considering the proposal
VitaDAO manages to raise $4.1M in a fundraising round
31.1.2023
VitaDAO has very successfully managed to raise an amount of $4.1 million for itself, through a fundraising round. This was made possible with the adequate amount of funding it received from the likes of Pfizer Ventures, Shine Capital, and L1 Digital. There were also decentralized science and Web3...
VitaDAO Closes $4.1M Funding Round With Pfizer Ventures for Longevity Research
31.1.2023
The decentralized autonomous organization is raising funds for research on technologies that target human aging
Molecule Partner With VitaDAO to Create Biopharma IP-to-NFT Transfer Using Nevermined Solution
19.8.2021
PRESS RELEASE. Molecule, a decentralised biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics...